Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 31–45 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-102
Acetylcholinesterase (AChE) Amniotic Fluid Test

This diagnostic test evaluates amniotic fluid for abnormal Acetylcholinesterase (AChE) enzyme isoform patterns, indicating the presence of open neural tube defects.

Amniotic Fluid 14–21 days 1,800.00 AED
View
View test specifications and preparation
What it measures
["Acetylcholinesterase (AChE) enzyme isoform patterns"]
Parameters
[]
Preparation
["No fasting required", "Disclose all current medications, supplements, and history of bleeding disorders to clinician", "Completed consent form (Form 35) required"]
Indications
["Pregnancies between 13 and 24 weeks gestation", "Clinical suspicion of open neural tube defect", "Elevated maternal serum alpha-fetoprotein", "Abnormal ultrasound findings"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 24468-2 ICD-10: Q05, Q01, Q00
Clinical summary
This diagnostic test evaluates amniotic fluid for abnormal Acetylcholinesterase (AChE) enzyme isoform patterns, indicating the presence of open neural tube defects.
TEST-5946
ACHE Gene Acetylcholinesterase Deficiency Genetic Test

This test identifies pathogenic variants in the ACHE gene associated with acetylcholinesterase deficiency.

Peripheral whole blood (5 mL EDTA) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACHE gene", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["No fasting is required", "Inform phlebotomist if taking anticoagulants", "Avoid blood-thinning medications for 24 hours before the draw unless otherwise advised by your doctor"]
Indications
["Individuals with a family history of abnormal anaesthesia reactions", "Individuals with unexplained post-operative respiratory failure", "Pre-anaesthetic risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77607-5 ICD-10: E85.8, Z13.71
Clinical summary
This test identifies pathogenic variants in the ACHE gene associated with acetylcholinesterase deficiency.
TEST-3707
ACOX1 Gene (Peroxisomal Acyl-CoA Oxidase Deficiency) Genetic Test

This test evaluates the ACOX1 gene for pathogenic variants associated with peroxisomal acyl-CoA oxidase deficiency.

Peripheral Whole Blood 21-28 Working Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACOX1 gene", "Single-nucleotide variants", "Small indels", "Copy-number changes"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue anti-epileptic medications or specialized dietary formulas without consultant direction"]
Indications
["Suspected peroxisomal acyl-CoA oxidase deficiency", "Severe neurological impairment in infancy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94541-6 ICD-10: E71.510
Clinical summary
This test evaluates the ACOX1 gene for pathogenic variants associated with peroxisomal acyl-CoA oxidase deficiency.
TEST-6105
ACP2 Gene Lysosomal Acid Phosphatase Deficiency Genetic Test

This genetic test evaluates the ACP2 gene for mutations associated with lysosomal acid phosphatase deficiency.

Whole blood 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["ACP2 gene mutations", "Point mutations", "Small indels", "Copy-number variations"]
Parameters
[]
Preparation
["Ensure adequate hydration", "Discontinue anticoagulants only under physician guidance", "Pre-test genetic counseling is mandatory"]
Indications
["Suspected lysosomal acid phosphatase deficiency", "Family history of the disorder", "Carrier screening in at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92851-1 ICD-10: E77.8
Clinical summary
This genetic test evaluates the ACP2 gene for mutations associated with lysosomal acid phosphatase deficiency.
TEST-5294
ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test

This test evaluates the ACTA1 gene for pathogenic variants associated with nemaline myopathy type 3.

Peripheral Venous Blood (EDTA) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACTA1 gene"]
Parameters
[]
Preparation
["Pre-test genetic counselling session required", "Informed consent required"]
Indications
["Unexplained muscle weakness", "Hypotonia", "Family history of congenital myopathies", "Suspected nemaline myopathy type 3"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88554-0 ICD-10: G71.2
Clinical summary
This test evaluates the ACTA1 gene for pathogenic variants associated with nemaline myopathy type 3.
TEST-4138
ACTA2 Gene Moyamoya Disease Type 5 Genetic Test

This test identifies genetic variants within the ACTA2 gene associated with Moyamoya disease type 5.

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single-nucleotide variants in ACTA2 gene", "Small insertions and deletions in ACTA2 gene", "Copy number changes in ACTA2 gene"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session required", "No fasting required", "No medication adjustments needed before blood draw"]
Indications
["Symptomatic individuals suspected of Moyamoya disease type 5", "Individuals with a positive family history of ACTA2-related disease", "Presymptomatic family members of affected individuals", "Confirmation of clinical diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81765-6 ICD-10: I67.5, Q28.8, Z15.89
Clinical summary
This test identifies genetic variants within the ACTA2 gene associated with Moyamoya disease type 5.
TEST-3079
ACTB Gene Baraitser-Winter Syndrome Type 1 Genetic Test

This genetic test identifies pathogenic variants within the ACTB gene, confirming a diagnosis of Baraitser-Winter syndrome type 1.

Blood (EDTA) or DNA FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACTB gene", "Coding exons and flanking intronic regions of ACTB"]
Parameters
[]
Preparation
["No fasting required", "Complete mandatory genetic counselling session", "Inform phlebotomist of all medications and supplements"]
Indications
["Suspected Baraitser-Winter syndrome type 1", "Need for definitive molecular diagnosis", "Genetic counselling for families with suspected cases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96527-2 ICD-10: Q87.8
Clinical summary
This genetic test identifies pathogenic variants within the ACTB gene, confirming a diagnosis of Baraitser-Winter syndrome type 1.
TEST-3052
ACTG1 Gene Baraitser‑Winter Syndrome Typeβ€―2 Genetic Test

This test identifies pathogenic variants in the ACTG1 gene associated with Baraitser‑Winter syndrome type 2.

Whole Blood (Peripheral) 3–4 weeks (stat reporting available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACTG1 gene"]
Parameters
[]
Preparation
["Provide detailed clinical history", "Provide a three-generation pedigree chart"]
Indications
["Suspected Baraitser‑Winter syndrome type 2", "Family history of Baraitser‑Winter syndrome type 2"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95075-6 ICD-10: Q87.0
Clinical summary
This test identifies pathogenic variants in the ACTG1 gene associated with Baraitser‑Winter syndrome type 2.
TEST-3316
ACTN1 Gene Bleeding Disorder, Platelet-Type 15 Genetic Test

This genetic test evaluates the ACTN1 gene for pathogenic variants associated with Platelet-Type 15 Bleeding Disorder.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACTN1 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy number alterations"]
Parameters
[]
Preparation
["No fasting required", "Provide detailed clinical history documenting bleeding symptoms", "Provide a three-generation family pedigree chart", "Provide any prior platelet function test results"]
Indications
["Suspected inherited platelet function defect", "Family history of Platelet-Type 15 Bleeding Disorder", "Evaluation of unexplained bleeding"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78041-7 ICD-10: D69.1
Clinical summary
This genetic test evaluates the ACTN1 gene for pathogenic variants associated with Platelet-Type 15 Bleeding Disorder.
TEST-110
Acute Kidney Injury (AKI) Panel Test

This diagnostic test evaluates kidney function by measuring serum and urine biomarkers associated with acute kidney injury.

Serum & Random Urine Same day (if sample reaches lab by 4 PM on Mon/Wed/Fri) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum creatinine", "Blood urea nitrogen (BUN)", "Cystatin C", "Urine biomarkers (Neutrophil gelatinase-associated lipocalin - NGAL)"]
Parameters
[{"name": "Serum Creatinine", "reference_range": null}, {"name": "Blood Urea Nitrogen (BUN)", "reference_range": null}, {"name": "Cystatin C", "reference_range": null}, {"name": "Neutrophil Gelatinase-Associated Lipocalin (NGAL)", "reference_range": null}]
Preparation
["No fasting required", "Maintain usual hydration"]
Indications
["Suspected acute kidney injury", "Monitoring kidney function in critically ill patients", "Distinguishing pre-renal from intrinsic renal injury"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 54089-8 ICD-10: N17.9
Clinical summary
This diagnostic test evaluates kidney function by measuring serum and urine biomarkers associated with acute kidney injury.
TEST-4588
ADA Gene Severe Combined Immunodeficiency (ADA-SCID) Genetic Test

This test identifies genetic mutations in the ADA gene responsible for Severe Combined Immunodeficiency (ADA-SCID). It uses Next-Generation Sequencing (NGS) for comprehensive analy...

Whole Blood (Peripheral) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ADA gene", "Single-nucleotide resolution"]
Parameters
[]
Preparation
["Pre-test genetic counseling required", "No specific fasting or medication adjustments needed"]
Indications
["Suspected ADA-SCID", "Confirmation of positive newborn screening", "Evaluation of severe immunodeficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21613-5 ICD-10: D81.3
Clinical summary
This test identifies genetic mutations in the ADA gene responsible for Severe Combined Immunodeficiency (ADA-SCID). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-3975
ADA2 Gene Sequencing for Childhood-Onset Polyarteritis Nodosa Test

This test evaluates the entire coding region of the ADA2 gene for mutations associated with DADA2.

Whole Blood (Venipuncture) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ADA2 gene mutations", "Adenosine deaminase 2 deficiency"]
Parameters
[]
Preparation
["Inform the phlebotomist about current medications.", "Inform the phlebotomist of any bleeding disorder or anticoagulant use."]
Indications
["Suspected DADA2", "Childhood-onset polyarteritis nodosa", "Recurrent unexplained fevers", "Family history of DADA2"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95034-2 ICD-10: M30.0
Clinical summary
This test evaluates the entire coding region of the ADA2 gene for mutations associated with DADA2.
TEST-5317
ADAM22 Gene Neurodevelopmental Disorder Genetic Test

This test detects pathogenic variants in the ADAM22 gene associated with severe neurodevelopmental disorders and early-onset epileptic encephalopathy.

Peripheral Whole Blood (5-10 mL) or Saliva (Oragene DNA Kit) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ADAM22 gene pathogenic variants (SNVs, indels, CNVs)", "Synaptic function related to ADAM22 protein"]
Parameters
[]
Preparation
["No specific fasting required", "Continue prescribed medications unless advised otherwise by physician"]
Indications
["Diagnosis of suspected ADAM22-related disorders", "Evaluation of early-onset epileptic encephalopathy", "Assessment of severe intellectual disability and autism spectrum traits"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101246-3 ICD-10: G40.89, F70-F79, F84.0
Clinical summary
This test detects pathogenic variants in the ADAM22 gene associated with severe neurodevelopmental disorders and early-onset epileptic encephalopathy.
TEST-3151
ADAMTS13 Gene Thrombotic Thrombocytopenic Purpura (TTP) Genetic Test

This genetic test identifies mutations in the ADAMTS13 gene associated with congenital Thrombotic Thrombocytopenic Purpura (TTP).

Whole Blood (EDTA) or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ADAMTS13 gene mutations", "Carrier status for congenital TTP"]
Parameters
[]
Preparation
["No fasting required", "Continue regular medications unless instructed otherwise"]
Indications
["Diagnosis of congenital TTP", "Carrier screening", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81311-5 ICD-10: M31.1
Clinical summary
This genetic test identifies mutations in the ADAMTS13 gene associated with congenital Thrombotic Thrombocytopenic Purpura (TTP).
TEST-5193
ADAMTS2 Gene Ehlers-Danlos Syndrome Type 7C (Dermatosparaxis) Genetic Test

This genetic test analyzes the ADAMTS2 gene for mutations associated with Ehlers-Danlos syndrome type VIIC (dermatosparaxis). It identifies pathogenic variants to confirm diagnosis...

Peripheral whole blood 3–4 Weeks (Rush option available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["ADAMTS2 gene sequence", "Pathogenic variants (mutations)", "Copy Number Variations (CNV)"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the lab about recent blood transfusions (
Indications
["Clinical suspicion of Ehlers-Danlos syndrome type VIIC (dermatosparaxis)", "Family history of dermatosparaxis", "Need for definitive genetic diagnosis for management and counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-7 ICD-10: Q79.6, Z14.01, Z82.79
Clinical summary
This genetic test analyzes the ADAMTS2 gene for mutations associated with Ehlers-Danlos syndrome type VIIC (dermatosparaxis). It identifies pathogenic variants to confirm diagnosis and guide patient management.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area